Exelon director Rogers acquires 897 stock-linked units
The deferred phantom share equivalents are settled in cash on a 1-for-1 basis when the director's board service ends.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Exelon Corp director Matthew C. Rogers acquired 897 deferred phantom share equivalents on September 30, 2026. His reported balance after the transaction was 2,436 equivalents, including 15 accrued through automatic dividend reinvestment. The equivalents are held in his Exelon stock fund account within a multi-fund, non-qualified deferred compensation plan and are settled for cash on a 1-for-1 basis upon termination of his board service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred phantom share equivalents F1, F2 | 897 | $40.40 | $36K |
Footnotes (2)
- F1. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
- F2. Balance includes 15 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.
Key Figures
Key Terms
non-qualified deferred compensation plan financial
automatic dividend reinvestment financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.